Clinical efficacy of ruxolitinib and chemotherapy in a child with Philadelphia chromosome-like acute lymphoblastic leukemia with GOLGA5-JAK2 fusion and induction failure

• Yang Y. Ding,
• Julie W. Stern,
• Tracey F. Jubelirer,
• Gerald B. Wertheim,
• Fumin Lin,
• Fengqi Chang,
• Zhaohui Gu,
• Charles G. Mullighan,
• Yong Li,
• Richard C. Harvey,
• I-Ming Chen,
• Cheryl L. Willman,
• Stephen P. Hunger,
• Marilyn M. Li,
• Sarah K. Tasian

Affiliations

Yang Y. Ding

Children’s Hospital of Philadelphia, Division of Oncology and Center for Childhood Cancer Research, PA, USA;University of Pennsylvania Perelman School of Medicine, Department of Pediatrics, PA, USA

Julie W. Stern

Children’s Hospital of Philadelphia, Division of Oncology and Center for Childhood Cancer Research, PA, USA;University of Pennsylvania Perelman School of Medicine, Department of Pediatrics, PA, USA

Tracey F. Jubelirer

Children’s Hospital of Philadelphia, Division of Oncology and Center for Childhood Cancer Research, PA, USA;University of Pennsylvania Perelman School of Medicine, Department of Pediatrics, PA, USA

Gerald B. Wertheim

University of Pennsylvania Perelman School of Medicine, Department of Pathology and Laboratory, PA, USA

Fumin Lin

Children’s Hospital of Philadelphia, Division of Genomic Diagnostics Medicine; Children’s Hospital of Philadelphia, Division of Hematopathology PA, USA

Fengqi Chang

Children’s Hospital of Philadelphia, Division of Genomic Diagnostics Medicine; Children’s Hospital of Philadelphia, Division of Hematopathology PA, USA

Zhaohui Gu

St Jude Children’s Research Hospital, Department of Pathology, Memphis, TN, USA

Charles G. Mullighan

St Jude Children’s Research Hospital, Department of Pathology, Memphis, TN, USA

Yong Li

Children’s Hospital of Philadelphia, Division of Oncology and Center for Childhood Cancer Research, PA, USA

Richard C. Harvey

University of New Mexico, Department of Pathology and Hematologic Malignancies Research Program, Albuquerque, NM, USA

I-Ming Chen

University of New Mexico, Department of Pathology and Hematologic Malignancies Research Program, Albuquerque, NM, USA

Cheryl L. Willman

University of New Mexico, Department of Pathology and Hematologic Malignancies Research Program, Albuquerque, NM, USA

Stephen P. Hunger

Children’s Hospital of Philadelphia, Division of Oncology and Center for Childhood Cancer Research, PA, USA;University of Pennsylvania Perelman School of Medicine, Department of Pediatrics, PA, USA

Marilyn M. Li

Children’s Hospital of Philadelphia, Division of Genomic Diagnostics Medicine; Children’s Hospital of Philadelphia, Division of Hematopathology PA, USA

Sarah K. Tasian

Children’s Hospital of Philadelphia, Division of Oncology and Center for Childhood Cancer Research, PA, USA;University of Pennsylvania Perelman School of Medicine, Department of Pediatrics, PA, USA